Thursday 15 October 2026
Export IVVD’s income statement to Excel — free account
Invivyd, Inc.
IVVD Healthcare Biotechnology
Invivyd, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $53.4 million, up 110.5% from fiscal 2024. In the quarter to June 2026, revenue grew 21.2%, EPS fell 16.7% and free cash flow fell 226.9%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years; insiders bought in the last twelve months.
0.67
0.06
+9.84%
Follow IVVD
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(67.94%) | (33.96%) | (60.34%) | (95.89%) | |
| (39.76%) | (25.83%) | (44.92%) | (69.69%) | ||
ROIC |
(480.14%) | (233.82%) | (270.46%) | (334.92%) | |
Return on Tangible Assets |
(89.97%) | (24.45%) | (44.36%) | (70.03%) | |
Average Days of Receivables |
71.86 | 95.09 | 76.10 | 70.18 | |
Free Cash Flow per Share |
(0.47) | (0.34) | (0.26) | (0.34) | |
Free Cash Flow |
(80.44) | (58.29) | (79.45) | (109.66) | |
Capital Expenditures |
(0.15) | (0.15) | (0.74) | (1.24) | |
| Other line items | |||||
Cash ROIC |
(45.18%) | (12.45%) | (20.52%) | (32.14%) | |
Accounts Receivable Turnover |
5.56 | 4.30 | 5.53 | 5.86 | |
Accounts Payable Turnover |
0.19 | 0.31 | 0.73 | 0.33 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
1,983.78 | 1,338.82 | 187.08 | 763.82 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
92.27% | 71.70% | 104.53% | 133.97% | |
Selling, General and Administrative Expense of Revenue |
125.45% | 125.28% | 134.78% | 151.07% | |
Share Based Compensation of Revenue |
24.25% | 21.79% | 20.61% | 19.24% | |
Operating CF/Net income |
1.34 | 1.11 | 1.01 | 1.01 | |
Depreciation/Fixed assets |
2.53 | 1.54 | 1.11 | 0.92 | |
Capex/Depreciation |
(0.05) | (0.07) | (0.39) | (0.61) | |
Revenue per Share |
0.29 | 0.31 | 0.18 | 0.18 | |
Operating CF per Share |
(0.47) | (0.34) | (0.25) | (0.34) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.01 | 0.02 |
Columns are period end dates